• 

  October 3, 2020

  Frequently Asked Questions About the Role of Maintenance Therapy in Cancer

  Charles H. Weaver, MD

• 

  July 11, 2020

  Kaposi’s Sarcoma

  Charles H. Weaver, MD

• 

  April 18, 2020

  Treatment of NTRK + Cancers

  Charles H. Weaver, MD

• 

  April 3, 2020

  Overview of Sarcomas

  Charles H. Weaver, MD

• 

  January 2, 2020

  Tazemetostat for Epithelioid Sarcoma

  Charles H. Weaver, MD

• 

  August 16, 2019

  Standing On Top of the World: Climbing Everest and Beating Cancer Twice

  Charles H. Weaver, MD

• 

  July 30, 2019

  NBTXR3 Combined with Radiation for Treatment of Soft Tissue Sarcoma

  Charles H. Weaver, MD

• 

  April 27, 2019

  Lartruvo® Confirmatory Study Fails to Show Benefit

  Charles H. Weaver, MD

• 

  February 9, 2019

  The CancerConnect Sarcoma Newsletter

  Charles H. Weaver, MD

• 

  October 10, 2018

  Yondelis Plus “PARP” Inhibitor Olaparib in Sarcoma is Feasible

  Charles H. Weaver, MD

• 

  September 20, 2018

  High-Dose Busulfan-Melphalan and ASCT Treatment Improves Treatment of Ewings

  Charles H. Weaver, MD

• 

  August 15, 2018

  Maintenance Therapy Significantly Improves Overall Survival in Rhabdomyosarcoma

  Charles H. Weaver, MD